Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-018226-29-NL
EUCTR2009-018226-29-NL
Active, Not Recruiting
N/A

The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gait

Not provided0 sites26 target enrollmentJanuary 20, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
Sponsor
Not provided
Enrollment
26
Status
Active, Not Recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • •\- age \>18 years
  • •\- six months ago after stroke
  • •\- patient walks with a stiff knee gait
  • •\- patient is able to walk independent
  • •\- overactivity of the m. rectus femoris is present, determined with EMG\-measurements
  • •\- patient is orientated in time, place and person
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Presentation of other conditions in joints which decrease walking
  • •\- Patient walks with a diminished knee flexion through an orthopedi cause
  • •\- Progressive clinical picture which influence gait
  • •\- Allergic reaction on Botox or a botulinum toxin product
  • •\- Botulinum toxin injection in the last 4 months
  • •\- Pregnancy and given breast feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42
IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Not Yet Recruiting
N/A
The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.Diseases of the nervous system
KCT0000530Yonsei University Health System, Severance Hospital30
Recruiting
N/A
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticitySpinal Cord Injury and Stroke
NL-OMON26235Sint Maartenskliniek Research10
Not Yet Recruiting
N/A
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity.
NL-OMON48057Stichting Sint Maartenskliniek10